we conclude from these studies that brl-3a cells , and particularly those of the subclone brl-3sc herein described , may provide an excellent model for investigations of somatomedin synthesis and release and that such studies are facilitated by the fact that rigf-ii released into serum-free medium appears to be the immediate product of de novo peptide synthesis .
C0037657
somatomedin
C0021666
rigf-ii